Related references
Note: Only part of the references are listed.Dual-functional capability of CD3+CD56+ CIK cells, a T-cell subset that acquires NK function and retains TCR-mediated specific cytotoxicity
Alice Pievani et al.
BLOOD (2011)
Tumor Immune Escape Mechanisms that Operate During Metastasis
D. O. Croci et al.
CURRENT PHARMACEUTICAL BIOTECHNOLOGY (2011)
Tumor-infiltrating immune cells and prognosis: the potential link between conventional cancer therapy and immunity
Caroline Jochems et al.
EXPERIMENTAL BIOLOGY AND MEDICINE (2011)
Tumor-derived intercellular adhesion molecule-1 mediates tumor-associated leukocyte infiltration in orthotopic pancreatic xenografts
Christina L. Roland et al.
EXPERIMENTAL BIOLOGY AND MEDICINE (2010)
E2F1 Induces Tumor Cell Survival via Nuclear Factor-κB-Dependent Induction of EGR1 Transcription in Prostate Cancer Cells
Chaogu Zheng et al.
CANCER RESEARCH (2009)
Elevated E2F1 inhibits transcription of the androgen receptor in metastatic hormone-resistant prostate cancer
Joanne N. Davis et al.
CANCER RESEARCH (2006)
Cytokine-induced killer cells against autologous CLL:: Direct cytotoxic effects and induction of immune accessory molecules by interferon-γ
Martin Kornacker et al.
INTERNATIONAL JOURNAL OF CANCER (2006)
Up regulation of ICAM-1 gene expression inhibits tumour growth and liver metastasis in colorectal carcinoma
A Tachimori et al.
EUROPEAN JOURNAL OF CANCER (2005)
Amplification of the lytic potential of effector/memory CD8+ cells by vector-based enhancement of ICAM-1 (CD54) in target cells:: implications for intratumoral vaccine therapy
DC Slavin-Chiorini et al.
CANCER GENE THERAPY (2004)
E2F1 and c-Myc potentiate apoptosis through inhibition of NF-κB activity that facilitates MnSOD-mediated ROS elimination
H Tanaka et al.
MOLECULAR CELL (2002)
Gene expression correlates of clinical prostate cancer behavior
D Singh et al.
CANCER CELL (2002)
Share Paper
